For the twenty-one million American adults experiencing major depressive disorder (MDD) annually, this FDA-cleared treatment ...

Major depressive disorder is one of the most common mental health conditions in the United States. It can have a severe impact on daily life. Treatment plans may include therapy, medication ...

A University of Queensland-led team analyzed data for 204 countries and territories, to assess global access to adequate ...

The wish to die is usually transient, or at least time-limited and reversible. Having a support system with an explicit plan ...

and predicted a positive outcome when the company reports data from a late-stage trial of its treatment for major depressive ...

b For adolescents with major depressive disorder or if OCD, posttraumatic stress disorder, or generalized anxiety disorder is present. c First-line treatment if drug interactions with fluoxetine ...

A constant sense of hopelessness and despair is a sign you may have major depression ... conditions. Depression can make you feel helpless. Taking charge of your treatment is one way to feel ...

The drug has shown strong results in phase 3 clinical trials, which are the basis for the new application to the FDA.

Depression, anxiety and other psychiatric conditions are common among cancer patients, but they are often undiagnosed due to mental health historically being deprioritized among healthcare ...

its Phase 3 pivotal program evaluating the efficacy and safety of CYB003 for the adjunctive treatment of Major Depressive Disorder (“MDD”). The program name, PARADIGM, represents the Company's ...

If you think you have symptoms of PTSD or depression, talk with your healthcare professional. They can help you begin the process of finding an appropriate treatment plan for your symptoms.

But this self-described workaholic's predisposition toward depression eventually emerged ... are expecting a second child and have a treatment plan in place.